{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:20:39Z","timestamp":1783146039475,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Major Special Projects for Four Major Chronic Diseases","award":["2024ZD0526202"],"award-info":[{"award-number":["2024ZD0526202"]}]},{"name":"Key Projects of Guangzhou Science and Technology Program","award":["2023B03J1287"],"award-info":[{"award-number":["2023B03J1287"]}]},{"name":"Key Projects of Guangzhou Science and Technology Program","award":["2023B01J1007"],"award-info":[{"award-number":["2023B01J1007"]}]},{"name":"Sun Yat-Sen University Clinical Research 5010 Program","award":["2020007"],"award-info":[{"award-number":["2020007"]}]},{"name":"Five-Year Plan Project of the Third Affiliated Hospital of Sun Yat-Sen University","award":["2023W106"],"award-info":[{"award-number":["2023W106"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12072-026-11083-7","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:59:59Z","timestamp":1775559599000},"page":"609-618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility and cost-effectiveness of a hospital-based hepatitis B management model in China: the \u2018Hot Wave Project\u2019 experience"],"prefix":"10.1007","volume":"20","author":[{"given":"Qiumin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-5750","authenticated-orcid":false,"given":"Liang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"4","key":"11083_CR1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S2468-1253(23)00321-7","volume":"9","author":"GS Cooke","year":"2024","unstructured":"Cooke GS, Flower B, Cunningham E, Marshall AD, Lazarus JV, Palayew A, et al. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update. Lancet Gastroenterol Hepatol. 2024;9(4):346\u2013365","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"11083_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.21037\/hbsn-2024-754","volume":"14","author":"R Yan","year":"2025","unstructured":"Yan R, Sun M, Yang H, Du S, Sun L, Mao Y. 2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges. Hepatobil Surg Nutr. 2025;14(1):66\u201377","journal-title":"Hepatobil Surg Nutr"},{"key":"11083_CR3","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva, Switzerland, 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240091672. Accessed August 13, 2025."},{"key":"11083_CR4","unstructured":"The CDA Foundation. Hepatitis B \u2013 China Mainland. July 22, 2025. https:\/\/cdafound.org\/polaris\/dashboard\/. Accessed August 13, 2025."},{"key":"11083_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101193","volume":"51","author":"Z Hui","year":"2024","unstructured":"Hui Z, Yu W, Fuzhen W, Liping S, Guomin Z, Jianhua L, et al. New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020. Lancet Reg Heal West Pac. 2024;51: 101193","journal-title":"Lancet Reg Heal West Pac"},{"issue":"2","key":"11083_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s11596-013-1113-z","volume":"33","author":"Q Fang","year":"2013","unstructured":"Fang Q, Hao Y-H, Li L, Zhang Z-H, Wang J-Z, Chen M-F, et al. Chronic HBV carrier\u2019s acceptance of regular surveilling program in China. J Huazhong Univ Sci Technol Med Sci. 2013;33(2):288\u2013292","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"1","key":"11083_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1186\/s12889-019-7061-1","volume":"19","author":"H Zheng","year":"2019","unstructured":"Zheng H, Zhang G, Wang F, Yin Z, Miao N, Sun X, et al. Self-motivated medical care-seeking behaviors and disease progression in a community-based cohort of chronic hepatitis B virus-infected patients in China. BMC Public Heal. 2019;19(1):901","journal-title":"BMC Public Heal"},{"key":"11083_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(25)00163-3","author":"AJ Stockdale","year":"2025","unstructured":"Stockdale AJ, Holt B, Bhadoria AS, Sadasivan A, Ikeda D, Pollack T, et al. Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2025. https:\/\/doi.org\/10.1016\/S2468-1253(25)00163-3","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"11083_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12072-021-10269-5","volume":"16","author":"M Kikuchi","year":"2022","unstructured":"Kikuchi M, Sawabe M, Aoyagi H, Wakae K, Watashi K, Hattori S, et al. Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers. Hep Int. 2022;16(1):68\u201380","journal-title":"Hep Int"},{"issue":"10","key":"11083_CR10","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/apt.18227","volume":"60","author":"E Vargas-Accarino","year":"2024","unstructured":"Vargas-Accarino E, Rando-Segura A, Palom A, Feliu-Prius A, Mart\u00ednez-Campreci\u00f3s J, Barreira A, et al. Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective study. Aliment Pharmacol Ther. 2024;60(10):1308\u20131314","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"11083_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/liv.15414","volume":"43","author":"R Jacob","year":"2023","unstructured":"Jacob R, Prince DS, Pipicella JL, Nguyen A, Bagatella M, Alvaro F, et al. Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to care. Liver Int. 2023;43(1):60\u201368","journal-title":"Liver Int"},{"key":"11083_CR12","unstructured":"National Bureau of Statistics of the People\u2019s Republic of China. Statistical Bulletin of the People\u2019s Republic of China on National Economic and Social Development, 2024. Beijing, China, 2025. https:\/\/www.stats.gov.cn\/sj\/zxfb\/202502\/t20250228_1958817.html. Accessed 10 March 2025."},{"key":"11083_CR13","unstructured":"Chinese Pharmaceutical Association. China Guidelines for Pharmacoeconomics Evaluation 2020. Chinese Pharmaceutical Association; 2020. https:\/\/www.cpa.org.cn\/cpadmn\/attached\/file\/20201203\/1606977380634185.pdf. Accessed 10 March 2025."},{"issue":"2","key":"11083_CR14","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1016\/S2214-109X(21)00517-9","volume":"10","author":"S Su","year":"2022","unstructured":"Su S, Wong WC, Zou Z, Cheng DD, Ong JJ, Chan P, et al. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation. Lancet Glob Health. 2022;10(2):e278\u2013e287","journal-title":"Lancet Glob Health"},{"issue":"1","key":"11083_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s43856-023-00420-8","volume":"3","author":"CA Picchio","year":"2023","unstructured":"Picchio CA, Nomah DK, Rando-Segura A, Buti M, Lens S, Forns X, et al. Community-based screening enhances hepatitis B virus linkage to care among West African migrants in Spain. Commun Med (Lond). 2023;3(1):182","journal-title":"Commun Med (Lond)"},{"key":"11083_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/v15071506","author":"A Palom","year":"2023","unstructured":"Palom A, Almandoz E, Madej\u00f3n A, Rando-Segura A, P\u00e9rez-Casta\u00f1o Y, Vico J, et al. Community strategy for hepatitis B, C, and D screening and linkage to care in Mongolians living in Spain. Viruses. 2023. https:\/\/doi.org\/10.3390\/v15071506","journal-title":"Viruses"},{"key":"11083_CR17","volume":"48","author":"K Hosking","year":"2024","unstructured":"Hosking K, Binks P, De Santis T, Wilson PM, Gurruwiwi GG, Bukulatjpi SM, et al. Evaluating a novel model of hepatitis B care, Hep B PAST, in the Northern Territory of Australia: results from a prospective, population-based study. Lancet Reg Heal. 2024;48: 101116","journal-title":"Lancet Reg Heal"},{"issue":"6","key":"11083_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70126","volume":"45","author":"A Not","year":"2025","unstructured":"Not A, Ouaarab-Essadek H, Montoro M, Trevi\u00f1o B, Buti M, Morillas RM, et al. Hepatitis B and C screening and linkage to care in migrants from endemic countries in Barcelona through a community action. Liver Int. 2025;45(6): e70126","journal-title":"Liver Int"},{"issue":"4","key":"11083_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.14020","volume":"32","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhang X, Yan X, Wang L, Ning M, Jia B, et al. A programme of hepatitis C surveillance with active linkage to care (HEAL) for inpatients in two tertiary hospitals in Jiangsu, China. J Viral Hepat. 2024;32(4): e14020","journal-title":"J Viral Hepat"},{"issue":"8","key":"11083_CR20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jval.2020.03.014","volume":"23","author":"J Williams","year":"2020","unstructured":"Williams J, Vickerman P, Douthwaite S, Nebbia G, Hunter L, Wong T, et al. An economic evaluation of the cost-effectiveness of opt-out hepatitis B and hepatitis C testing in an emergency department setting in the United Kingdom. Value Heal. 2020;23(8):1003\u20131011","journal-title":"Value Heal"},{"issue":"1","key":"11083_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100932","volume":"6","author":"J Llaneras","year":"2024","unstructured":"Llaneras J, Ruiz-Cobo JC, Rando-Segura A, Barreira-D\u00edaz A, Dom\u00ednguez-Hern\u00e1ndez R, Rodr\u00edguez-Fr\u00edas F, et al. Integrating viral hepatitis management into the emergency department: a further step towards viral hepatitis elimination. JHEP Rep. 2024;6(1): 100932","journal-title":"JHEP Rep"},{"key":"11083_CR22","volume":"35","author":"L Zhang","year":"2023","unstructured":"Zhang L, Liu H, Zou Z, Su S, Ong JJ, Ji F, et al. Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divide. Lancet Reg Heal. 2023;35: 100737","journal-title":"Lancet Reg Heal"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11083-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11083-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11083-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:57:42Z","timestamp":1783144662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-026-11083-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["11083"],"URL":"https:\/\/doi.org\/10.1007\/s12072-026-11083-7","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that there are no known financial or personal conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University (Approval No. II2024-287\u201301). This study was conducted in accordance with the ethical standards of the Ethics Committee of Third Affiliated Hospital of Sun Yat-sen University and with the Helsinki Declaration. This study involved the analysis of existing clinical data derived from hospital management improvements and posed no more than minimal risk to participants. All patient data were anonymized and deidentified prior to analysis to ensure strict confidentiality and privacy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}